CHAI is working with our partners to eliminate TB, helping governments better identify, diagnose, treat, and prevent the disease to save lives and decrease transmission. We work with suppliers and governments to facilitate the introduction of new quality-assured products at lower prices that offer higher cure rates, shorter treatment durations, and fewer side effects.

We support countries with innovative tools to find those who may be infected and get them treated early through the introduction and scale-up of new TB diagnostics. We help accelerate the adoption of treatment algorithms and service delivery innovations for drug-resistant TB. We are also working with countries to roll out shorter preventative treatments to vulnerable, high-risk populations, including people living with HIV, children, and contacts of those with the disease to prevent the active form of the disease.